[av_section min_height=” min_height_px=’500px’ padding=’default’ shadow=’no-shadow’ bottom_border=’no-border-styling’ bottom_border_diagonal_color=’#333333′ bottom_border_diagonal_direction=” bottom_border_style=” custom_arrow_bg=” id=’#Speaker’ color=’main_color’ custom_bg=” src=” attachment=” attachment_size=” attach=’scroll’ position=’top left’ repeat=’no-repeat’ video=” video_ratio=’16:9′ overlay_opacity=’0.5′ overlay_color=” overlay_pattern=” overlay_custom_pattern=” av_element_hidden_in_editor=’0′]
[av_textblock size=” font_color=” color=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” admin_preview_bg=”]

Key Speakers

[/av_textblock]

[av_textblock size=” font_color=” color=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” admin_preview_bg=”]
Radical Transformation of Life Sciences in Asia

Bio Investment Asia 2019 provides robust opportunities to network with the right partners. To attend the Bio Investment Asia, you will meet with international biotechnology firms and access to over 25 sessions, and networking opportunities with 9,000++ attendees from 30 countries. The event offers the business forum, conference sessions covering life sciences trends, policy & regulatory issues, research funding opportunities, startups, technology transfer, clinical trial and exhibition.
[/av_textblock]

[av_one_fifth first min_height=” vertical_alignment=” space=” custom_margin=” margin=’0px’ padding=’0px’ border=” border_color=” radius=’0px’ background_color=” src=” background_position=’top left’ background_repeat=’no-repeat’ animation=” mobile_breaking=” mobile_display=”]

[av_team_member name=” job=” src=’https://www.bioinvestmentasia.com/wp-content/uploads/2019/09/Damond.png’ attachment=’667′ attachment_size=’full’ image_width=” description=’ Mr. Joseph Damond
Executive Vice President, International Affairs, Biotechnology Innovation Organization (BIO), USA’ font_color=” custom_title=” custom_content=” admin_preview_bg=”][/av_team_member]

[/av_one_fifth][av_one_fifth min_height=” vertical_alignment=” space=” custom_margin=” margin=’0px’ padding=’0px’ border=” border_color=” radius=’0px’ background_color=” src=” background_position=’top left’ background_repeat=’no-repeat’ animation=” mobile_breaking=” mobile_display=”]

[av_team_member name=” job=” src=’https://www.bioinvestmentasia.com/wp-content/uploads/2019/09/Ruth.png’ attachment=’662′ attachment_size=’full’ image_width=” description=’Ms. Ruth Lee Choo Ai
Associate Director, Public Policy and Regulatory Affairs United States Pharmacopeia (USP)Singapore’ font_color=” custom_title=” custom_content=” admin_preview_bg=”][/av_team_member]

[av_team_member name=” job=” src=’https://www.bioinvestmentasia.com/wp-content/uploads/2019/09/Matt.png’ attachment=’661′ attachment_size=’full’ image_width=” description=’Prof Matthew Bellgard
Chair, APEC LSIF Rare Disease Network; Director, eResearch, Queensland University of Technology (QUT), Australia’ font_color=” custom_title=” custom_content=” admin_preview_bg=”][/av_team_member]

[av_team_member name=” job=” src=’https://www.bioinvestmentasia.com/wp-content/uploads/2019/09/Mark.png’ attachment=’660′ attachment_size=’full’ image_width=” description=’ Mr. Mark Punyanitya
Co-Founder, President, CEO PhenoMx, Inc., USA’ font_color=” custom_title=” custom_content=” admin_preview_bg=”][/av_team_member]

[/av_one_fifth][av_hr class=’default’ height=’50’ shadow=’no-shadow’ position=’center’ custom_border=’av-border-thin’ custom_width=’50px’ custom_border_color=” custom_margin_top=’30px’ custom_margin_bottom=’30px’ icon_select=’yes’ custom_icon_color=” icon=’ue808′ av-desktop-hide=” av-medium-hide=” av-small-hide=” av-mini-hide=”]

[av_team_member name=” job=” src=’https://www.bioinvestmentasia.com/wp-content/uploads/2019/09/Agne_2cm.png’ attachment=’664′ attachment_size=’full’ image_width=” description=’ Dr. Agne Vaitkeviciene
Head of Research abd Development, Life Sciences, Verita Healthcare Group Ltd., Singapore’ font_color=” custom_title=” custom_content=” admin_preview_bg=”][/av_team_member]

[av_team_member name=” job=” src=’https://www.bioinvestmentasia.com/wp-content/uploads/2019/09/Adrian_2cm.png’ attachment=’663′ attachment_size=’full’ image_width=” description=’Mr. Adrián Gutiérrez
Head of Science & Technology Department at Embassy of Spain – CDTI´s Chief Representative for India and Southeast Asia’ font_color=” custom_title=” custom_content=” admin_preview_bg=”][/av_team_member]

[av_team_member name=” job=” src=’https://www.bioinvestmentasia.com/wp-content/uploads/2019/09/Akshat_2cm.png’ attachment=’665′ attachment_size=’full’ image_width=” description=’Mr. Akshat Kshetrapal
Director Rockstart Health Accelerator The Netherland’ font_color=” custom_title=” custom_content=” admin_preview_bg=”][/av_team_member]

[av_team_member name=” job=” src=’https://www.bioinvestmentasia.com/wp-content/uploads/2019/09/Alexander_2cm.png’ attachment=’666′ attachment_size=’full’ image_width=” description=’Prof. Alexander G Haslberger
Vienna University, Austria’ font_color=” custom_title=” custom_content=” admin_preview_bg=”][/av_team_member]

[/av_one_fifth]
[/av_section]

[av_section min_height=” min_height_px=’500px’ padding=’default’ shadow=’no-shadow’ bottom_border=’no-border-styling’ bottom_border_diagonal_color=’#333333′ bottom_border_diagonal_direction=” bottom_border_style=” custom_arrow_bg=” id=’#program’ color=’main_color’ custom_bg=” src=” attachment=” attachment_size=” attach=’scroll’ position=’top left’ repeat=’no-repeat’ video=” video_ratio=’16:9′ overlay_opacity=’0.5′ overlay_color=” overlay_pattern=” overlay_custom_pattern=” av_element_hidden_in_editor=’0′]